The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kalyuzhin O.V.

Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russia, Moscow, Russia

Ponezheva Zh.B.

Clinical Department of Infectious Pathology, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Welfare, Moscow, Russia

Semenova I.V.

Sankt-Peterburgskiĭ NII skoroĭ pomoshchi im. I.I. Dzhanelidze

Khokhlova O.N.

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Welfare, Moscow, Russia

Serebrovskaya L.V.

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Welfare, Moscow, Russia

Guseva T.S.

NII pidemiologii i mikrobiologii im. N.F. Gamalei Minzdrava RF, Moskva, Rossiia, 123098

Parshina O.V.

NII pidemiologii i mikrobiologii im. N.F. Gamalei Minzdrava RF, Moskva, Rossiia, 123098

Maleev V.V.

FBUN «Tsentral'nyj nauchno-issledovatel'skij institut epidemiologii» Rospotrebnadzora, Moskva

Lymphocyte subpopulations, levels of interferon, and expression of their receptors in patients with chronic hepatitis B and C: Correlation with the species of viruses and the degree of liver fibrosis

Authors:

Kalyuzhin O.V., Ponezheva Zh.B., Semenova I.V., Khokhlova O.N., Serebrovskaya L.V., Guseva T.S., Parshina O.V., Maleev V.V.

More about the authors

Journal: Therapeutic Archive. 2017;89(11): 14‑20

Read: 3677 times


To cite this article:

Kalyuzhin OV, Ponezheva ZhB, Semenova IV, et al. . Lymphocyte subpopulations, levels of interferon, and expression of their receptors in patients with chronic hepatitis B and C: Correlation with the species of viruses and the degree of liver fibrosis. Therapeutic Archive. 2017;89(11):14‑20. (In Russ.)
https://doi.org/10.17116/terarkh2017891114-20

Recommended articles:

References:

  1. Yang Y, Zhou Y, Hou J, Bai C, Li Z, Fan J, Ng IO, Zhou W, Sun H, Dong Q, Lee JM, Lo CM, Man K, Yang Y, Li N, Ding G, Yu Y, Cao X. Hepatic IFIT3 predicts interferon-α therapeutic response in patients of hepatocellular carcinoma. Hepatology. 2017. https://doi.org/10.1002/hep.29156
  2. Boisvert M, Shoukry NH. Type III interferons in hepatitis C virus infection. Front Immunol. 2016;7:628. https://doi.org/10.3389/fimmu.2016.00628
  3. Lin Z, Zhang J, Ma X, Yang S, Tian N, Lin X, Zhou S, Liu L, Gao Y. The Role of Interferon Lambda 3 Genetic Polymorphisms in Response to Interferon Therapy in Chronic Hepatitis B Patients: An Updated Meta-Analysis. Hepat Mon. 2016;16(7): e37534. https://doi.org/10.5812/hepatmon.37534
  4. Tillmann HL, Thompson AJ, Patel K, Wiese M, Tenckhoff H, Nischalke HD, Lokhnygina Y, Kullig U, Göbel U, Capka E, Wiegand J, Schiefke I, Güthoff W, Grüngreiff K, König I, Spengler U, McCarthy J, Shianna KV, Goldstein DB, McHutchison JG, Timm J, Nattermann J; German Anti-D Study Group. A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice. Gastroenterology. 2010;139:1586-1592. https://doi.org/1592e1581.10.1053/j.gastro.2010.07.005
  5. Chen CL, Huang JY, Wang CH, Tahara SM, Zhou L, Kondo Y, Schechter J, Su L, Lai MM, Wakita T, Cosset FL, Jung JU, Machida K. Hepatitis C virus has a genetically determined lymphotropism through co-receptor B7.2. Nat Commun. 2017;8:13882. https://doi.org/10.1038/ncomms13882
  6. Sinha M, Rao CR, Premalata CS, Shafiulla M, Lakshmaiah KC, Jacob LA, Babu GK, Viveka BK, Appaji L, Subramanyam JR. Plasma Epstein-Barr virus and Hepatitis B virus in non-Hodgkin lymphomas: Two lymphotropic, potentially oncogenic, latently occurring DNA viruses. Indian J Med Paediatr Oncol. 2016; 37(3):146-151. https://doi.org/10.4103/0971-5851.190353
  7. Kuo M-T, Hu T-H, Lu S-N, Hung CH, Wang J-H, Chen C-H, Chiu Y-C, Lee C-M. Neutrophil-to-lymphocyte ratio as a predictor of response to peginterferon plus ribavirin therapy for chronic hepatitis C. Disease Markers. 2014;2014:462958. https://doi.org/10.1155/2014/462958
  8. Gomez D, Farid S, Malik H Z, Young AL, Toogood GJ, Lodge JPA, Prasad KR. Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. World Journal of Surgery. 2008;32(8):1757-1762. https://doi.org/10.1007/s00268-008-9552-6
  9. Chen T-M, Lin C-C, Huang P-T, Wen C-F. Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation. Journal of Gastroenterology and Hepatology. 2012;27(3):553-561. https://doi.org/10.1111/j.1440-1746.2011.06910.x
  10. Karasu Z, Tekin F, Ersoz G, Gunsar F, Batur Y, Ilter T, Akarca US. Liver fibrosis is associated with decreased peripheral platelet count in patients with chronic hepatitis B and C. Dig Dis Sci. 2007;52(6):1535-1539. https://doi.org/10.1007/s10620-006-9144-y
  11. Al-Qahtani A, Al-Anazi M, Abdo AA, Sanai FM, Al-Hamoudi W, Alswat KA, Al-Ashgar HI, Khan MQ, Albenmousa A, Khalaf Nisreen, Viswan N, Al-Ahdal MN. Correlation between genetic variations and serum level of interleukin 28B with virus genotypes and disease progression in chronic hepatitis C virus infection. Journal of Immunology Research. 2015;2015:768470. https://doi.org/10.1155/2015/768470
  12. Depla M, Pelletier S, Bedard N, Brunaud C, Bruneau J, Shoukry NH. IFN-lambda3 polymorphism indirectly influences NK cell phenotype and function during acute HCV infection. Immun Inflamm Dis. 2016;4:376-388. https://doi.org/10.1002/iid3.122
  13. Dolganiuc A, Kodys K, Marshall C, Saha B, Zhang S, Bala S, et al. Type III interferons, IL-28 and IL-29, are increased in chronic HCV infection and induce myeloid dendritic cell-mediated FoxP3+ regulatory T cells. PLoS One. 2012;7:e44915. https://doi.org/10.1371/journal.pone.0044915
  14. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature. 2009;461:399-401. https://doi.org/10.1038/nature08309
  15. Langhans B, Kupfer B, Braunschweiger I, Arndt S, Schulte W, Nischalke HD, et al. Interferon-lambda serum levels in hepatitis C. J Hepatol. 2011;54:859-865. https://doi.org/10.1016/j.jhep.2010.08.020
  16. Torres C, Brahm J, Venegas M. Lambda interferon serum levels in patients with chronic hepatitis C virus infection according to their response to therapy with pegylated interferon and ribavirin. J Interferon Cytokine Res. 2014;34:106-110. https://doi.org/10.1089/jir.2013.0005
  17. Nguyen KB, Watford WT, Salomon R, Hofmann SR, Pien GC, Morinobu A, Gadina M, O’Shea JJ, Biron CA. Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection. Science. 2002;297:2063-2066. https://doi.org/10.1126/science.1074900
  18. Pien GC, Nguyen KB, Malmgaard L, Satoskar AR, Biron CA. A unique mechanism for innate cytokine promotion of T cell responses to viral infections. J Immunol. 2002;169:5827-5837. https://doi.org/10.4049/jimmunol.169.10.5827
  19. Dontsov DV, Romanova EB, Ambalov YuM. The method of alternative analysis Wald for prognosis progression of disease in patients with chronic hepatitis C. Kubanskij nauchnyj medicinskij vestnik. 2011;4(127):69-71. Accessed May 21, 2017. Available at: http://cyberleninka.ru/article/n/metod-alternativnogo-analiza-valda-kak-sposob-prognoza-progressirovaniya-zabolevaniya-u-bolnyh-hronicheskim-gepatitom-s (In Russ.)
  20. Weng HL, Wang BE, Jia JD, Wu WF, Xian JZ, Mertens PR, Cai WM, Dooley S. Effect of interferon-gamma on hepatic fibrosis in chronic hepatitis B virus infection: a randomized controlled study. Clin Gastroenterol Hepatol. 2005;3(8):819-828. (In Russ.) https://doi.org/10.1016/s1542-3565(05)00404-0
  21. Muir AJ, Sylvestre PB, Rockey DC. Interferon gamma-1b for the treatment of fibrosis in chronic hepatitis C infection. J Viral Hepat. 2006;13(5):322-328. https://doi.org/10.1111/j.1365-2893.2005.00689.x
  22. Knight B, Lim R, Yeoh GC, Olynyk JK. Interferon-gamma exacerbates liver damage, the hepatic progenitor cell response and fibrosis in a mouse model of chronic liver injury. J Hepatol. 2007;47(6):826-833. https://doi.org/10.1016/j.jhep.2007.06.022

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.